HemaSphere
(Jun 2022)
P627: COMBINED DRUG AND CRISPR/CAS9 SCREENING REVEALS SPECIFIC TARGETS FOR SF3B1- AND NOTCH1-MUTATED CLL CELLS
- L. Dostálová,
- A. Ladungová,
- D. Škrnová,
- N. Varma Gottumukkala,
- Y. Lodhi,
- M. Smida
Affiliations
- L. Dostálová
- 1 CEITEC Masaryk University
- A. Ladungová
- 1 CEITEC Masaryk University
- D. Škrnová
- 1 CEITEC Masaryk University
- N. Varma Gottumukkala
- 1 CEITEC Masaryk University
- Y. Lodhi
- 1 CEITEC Masaryk University
- M. Smida
- 1 CEITEC Masaryk University
- DOI
-
https://doi.org/10.1097/01.HS9.0000845396.09812.76
- Journal volume & issue
-
Vol. 6
pp.
526
– 527
WeChat QR code